The first QuiremScout® cases have been successfully performed by clinical teams in Dresden and Pisa last week. We congratulate the clinical teams, and everyone involved! QuiremScout® is the first and only CE-marked SIRT work-up product that consists of the same particle as the therapeutic microspheres. It improves the accuracy of SIRT work-up when compared to 99mTc-MAA, and aims to optimize patient selection and advance treatment planning.
Update: the uniklinikum Dresden have published their own (German) newsitem about the procedure, which you can find here.